Company Profiles

driven by the PitchBook Platform

Nora Therapeutics

Description

Developer of therapeutics to address unmet needs in reproductive medicine. The company develops NT100 which is a novel treatment to reduce the risk of miscarriage in women who have a history of unexplained recurrent miscarriage.

1992

Founded

PRIVATE

Status

Later Stage VC

Latest Deal Type

$1M

Latest Deal Amount

$53.9M

Total Amount Raised

6

Investors

Description

Developer of therapeutics to address unmet needs in reproductive medicine. The company develops NT100 which is a novel treatment to reduce the risk of miscarriage in women who have a history of unexplained recurrent miscarriage.

Website:

www.noratherapeutics.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Pharmaceuticals

Other Industries

Drug Discovery
Therapeutic Devices

Primary Office

530 Lytton Avenue 2nd floor Palo Alto, CA 94301United States +1 (650) 479-5331
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Nora Therapeutics's full profile, request a free trial.

Nora Therapeutics Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Nora Therapeutics Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Nora Therapeutics Investors (6)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Burrill & CoMerchant Banking FirmMinority000 0000000 0000
NovoCorporate Venture CapitalMinority000 0000000 0000
Prospect Venture PartnersVenture CapitalMinority000 0000000 0000
Rho VenturesVenture CapitalMinority000 0000000 0000
TEDCOVenture CapitalMinority000 0000000 0000
Burrill & Co Merchant Banking Firm
Novo Corporate Venture Capital
Prospect Venture Partners Venture Capital
Rho Ventures Venture Capital
TEDCO Venture Capital

Nora Therapeutics Executive Team (5)

NameTitleBoard
Seat
Contact
Info
Jeffrey Tong Ph.DPresident, Board Member & Chief Executive Officer
Chris McClainExecutive Director, Business Affairs & Co-Founder
Darryl Carter MDOwner, Co-Founder & Vice President, Research
Sandra ShpilbergVice President, Strategic Marketing & Commercial Planning
Mark JoingVice President, Clinical Operations & Project Management
Jeffrey Tong Ph.D President, Board Member & Chief Executive Officer
Chris McClain Executive Director, Business Affairs & Co-Founder
Darryl Carter MD Owner, Co-Founder & Vice President, Research
Sandra Shpilberg Vice President, Strategic Marketing & Commercial Planning
Mark Joing Vice President, Clinical Operations & Project Management

Nora Therapeutics Board Members (9)

NameRepresentingRoleSinceContact
Info
Anupam Dalal MDSelfBoard Member000 0000
Chen-Ming Yu MDVivo CapitalManaging Partner000 0000
David Schnell MDProspect Venture PartnersCo-Founder, Partner & Managing Director000 0000
Dennis Fenton Ph.DSelfBoard Member000 0000
Donald Hayden Jr.Prospect Venture PartnersSenior Advisor000 0000
Anupam Dalal MD Board Member Self
Chen-Ming Yu MD Managing Partner Vivo Capital
David Schnell MD Co-Founder, Partner & Managing Director Prospect Venture Partners
Dennis Fenton Ph.D Board Member Self
Donald Hayden Jr. Senior Advisor Prospect Venture Partners
Request full access to PitchBook